BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15852992)

  • 1. Decreased mivacurium infusion rate and delayed neuromuscular recovery after metoclopramide: a randomized double blind placebo-controlled study.
    El Ayass N; Hendrickx P
    Eur J Anaesthesiol; 2005 Mar; 22(3):197-201. PubMed ID: 15852992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased mivacurium requirements and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults.
    Bevan JC; Reimer EJ; Smith MF; Scheepers L deV ; Bridge HS; Martin GR; Bevan DR
    Anesth Analg; 1998 Oct; 87(4):772-8. PubMed ID: 9768768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium.
    Skinner HJ; Girling KJ; Whitehurst A; Nathanson MH
    Br J Anaesth; 1999 Apr; 82(4):542-5. PubMed ID: 10472219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metoclopramide on mivacurium-induced neuromuscular block.
    Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
    Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged mivacurium infusion in young and elderly adults.
    Goudsouzian N; Chakravorti S; Denman W; Schwartz A; Yang HS; Cook DR
    Can J Anaesth; 1997 Sep; 44(9):955-62. PubMed ID: 9305559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
    Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
    Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR
    Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mivacurium and suxamethonium administered by bolus and infusion.
    Brandom BW; Woelfel SK; Cook DR; Weber S; Powers DM; Weakly JN
    Br J Anaesth; 1989 May; 62(5):488-93. PubMed ID: 2525044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The infusion rate of mivacurium and its spontaneous neuromuscular recovery in magnesium-treated parturients.
    Ahn EK; Bai SJ; Cho BJ; Shin YS
    Anesth Analg; 1998 Mar; 86(3):523-6. PubMed ID: 9495406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do metoclopramide and ondansetrone alter mivacurium-induced neuromuscular blockade? - a randomised trial.
    Tercan M; Efe EM; Turker G; Kaya FN; Yavascaoglu B; Ozarda Y; Mogol EB
    Braz J Anesthesiol; 2014; 64(1):35-9. PubMed ID: 24565386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mivacurium chloride administration by infusion.
    Apfelbaum JL
    Acta Anaesthesiol Scand Suppl; 1995; 106():55-7. PubMed ID: 8533547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
    Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.
    Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of mivacurium dosage requirements during isoflurane and desflurane anesthesia.
    Gan TJ; Quill TJ; Pressley C; Parrillo S; Glass PS
    J Clin Anesth; 1996 Jun; 8(4):301-6. PubMed ID: 8695134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antagonism of mivacurium-induced neuromuscular block on postoperative emesis in children.
    Watcha MF; Safavi FZ; McCulloch DA; Tan TS; White PF
    Anesth Analg; 1995 Apr; 80(4):713-7. PubMed ID: 7893023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.